新芝生物
(920685)
| 流通市值：6.78亿 | | | 总市值：10.63亿 |
| 流通股本：5831.40万 | | | 总股本：9151.60万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 74,830,127.16 | 104,507,664.74 | 96,635,915.5 | 90,243,426.33 |
| 交易性金融资产 | 246,396,430.35 | 224,434,773.94 | 259,678,722.39 | 244,953,504.69 |
| 应收票据及应收账款 | 14,989,404.62 | 10,041,713.65 | 10,503,993.49 | 11,435,777.73 |
| 其中：应收票据 | 2,432,265.87 | 837,083 | 1,517,563.77 | 649,076 |
| 应收账款 | 12,557,138.75 | 9,204,630.65 | 8,986,429.72 | 10,786,701.73 |
| 应收款项融资 | 1,766,212.91 | 1,249,560 | 309,240 | 0 |
| 预付款项 | 5,554,182.32 | 6,882,572.18 | 3,990,214.54 | 3,433,539.66 |
| 其他应收款合计 | 432,859.07 | 828,574.9 | 623,616.1 | 842,830.67 |
| 存货 | 73,828,955.86 | 60,186,501.08 | 49,616,125.14 | 49,507,413.28 |
| 其他流动资产 | 1,617,993.27 | 1,226,248.19 | 771,303.28 | 3,352,710.77 |
| 流动资产合计 | 419,416,165.56 | 409,357,608.68 | 422,129,130.44 | 403,769,203.13 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 0 |
| 固定资产 | 108,098,855.23 | 35,190,269.93 | 36,306,054.25 | 33,170,065.49 |
| 在建工程 | 67,643,861.23 | 139,827,940.38 | 139,674,850.52 | 139,420,864.05 |
| 使用权资产 | 7,641,394.03 | 8,367,982.15 | 9,094,570.27 | 5,820,940.33 |
| 无形资产 | 20,849,136.81 | 20,985,725.24 | 21,138,537.68 | 21,301,294.12 |
| 商誉 | 6,868,485.01 | 6,868,485.01 | 6,868,485.01 | 6,868,485.01 |
| 长期待摊费用 | 361,333.03 | 563,816.75 | 704,119.67 | 909,407.04 |
| 递延所得税资产 | 1,414,815.31 | 1,269,130.92 | 1,103,838.78 | 858,496.27 |
| 其他非流动资产 | 46,215,818.26 | 44,076,241.89 | 43,554,299.01 | 45,208,661.53 |
| 非流动资产合计 | 259,093,698.91 | 257,149,592.27 | 258,444,755.19 | 253,558,213.84 |
| 资产总计 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 | 657,327,416.97 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 0 |
| 应付票据及应付账款 | 35,202,741.55 | 32,602,078.69 | 31,557,467.98 | 38,556,114.84 |
| 应付账款 | 35,202,741.55 | 32,602,078.69 | 31,557,467.98 | 38,556,114.84 |
| 合同负债 | 27,201,935.24 | 20,687,437.41 | 18,891,353.05 | 14,543,671.12 |
| 应付职工薪酬 | 12,103,554.34 | 7,719,403.94 | 17,424,989.91 | 13,974,740.06 |
| 应交税费 | 2,842,044.49 | 2,055,322.97 | 3,895,014.71 | 2,752,540.53 |
| 其他应付款合计 | 148,095.09 | 182,535.51 | 312,677.39 | 134,404.21 |
| 一年内到期的非流动负债 | 2,769,616.61 | 2,793,574.1 | 2,822,094.07 | 1,525,199.99 |
| 其他流动负债 | 2,103,324.01 | 2,423,180.96 | 2,408,197.46 | 1,607,276.72 |
| 流动负债合计 | 82,371,311.33 | 68,463,533.58 | 77,311,794.57 | 73,093,947.47 |
| 非流动负债: | | | | |
| 租赁负债 | 4,553,907.59 | 5,079,388.63 | 5,910,007.04 | 3,750,982.34 |
| 递延所得税负债 | - | 3,280.31 | 3,600.2 | - |
| 非流动负债合计 | 4,553,907.59 | 5,082,668.94 | 5,913,607.24 | 3,750,982.34 |
| 负债合计 | 86,925,218.92 | 73,546,202.52 | 83,225,401.81 | 76,844,929.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 91,515,941 | 91,515,941 | 91,515,941 | 91,515,941 |
| 资本公积 | 352,510,679.01 | 352,510,679.01 | 352,510,679.01 | 352,510,679.01 |
| 减:库存股 | 28,235,967.38 | 28,235,967.38 | 28,235,967.38 | 28,235,967.38 |
| 盈余公积 | 35,416,168.75 | 35,416,168.75 | 35,416,168.75 | 31,802,029.18 |
| 未分配利润 | 110,476,042.13 | 114,166,245.46 | 107,208,413.55 | 96,326,927.78 |
| 归属于母公司股东权益合计 | 561,682,863.51 | 565,373,066.84 | 558,415,234.93 | 543,919,609.59 |
| 少数股东权益 | 29,901,782.04 | 27,587,931.59 | 38,933,248.89 | 36,562,877.57 |
| 股东权益合计 | 591,584,645.55 | 592,960,998.43 | 597,348,483.82 | 580,482,487.16 |
| 负债和股东权益合计 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 | 657,327,416.97 |
| 公告日期 | 2026-08-26 | 2026-04-27 | 2026-04-27 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |